FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Study suggests estrogen may trigger binge drinking
The female hormone estrogen appears to promote binge drinking in women, a new mouse study published recently in the journal ...
Becker's Hospital Review1d
5 Ozempic updates
Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.
FDA approves Zepbound for sleep apnea in obese adults
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...
Knowridge1d
FDA approves first drug for sleep apnea treatment
The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug ...
KSL4d
Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea
The FDA on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug ...
Alaska Dispatch News6dOpinion
Opinion: We’ve accepted Wegovy and Zepbound. The next phase is harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
The FDA also recommends that prescribed users reduce their caloric intake and increase their exercise The weight loss drug ...
Newsable Asianet News on MSN6d
Weight loss drug Zepbound gets US FDA nod to treat sleep apnea; India launch expected in 2025
In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known ...